Showing 6571-6580 of 10741 results for "".
Sclerotherapy - Part 3
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/sclerotherapy-part-3/19500/This is the third video in a series of four.Beyond Skin Clearance: What Patient-Reported Outcomes Reveal in Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-updates-in-atopic-dermatitis/beyond-skin-clearance-what-patient-reported-outcomes-reveal-in-atopic-dermatitis/57286/Michael Lewitt, MD, FAAD, explains how patient-reported outcomes capture itch, sleep, pain, treatment experience, and other dimensions of atopic dermatitis that clinical measures may miss.Contributing to Scalp Health with an Advanced Shampoo Formulation
https://practicaldermatology.com/videos/c-suite-chats/contributing-to-scalp-health-with-an-advanced-shampoo-formulation/70077/David Stachura, PhD, of FACTORFIVE Skincare, explains why scalp health is a hot topic in dermatology practices and and how a new sulfate-free shampoo combines human stem cell conditioned media with ingredients such as hydrolyzed wheat protein, panthenol, aloe vera, and argan oil.Oxidative Stress and Antioxidants in Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/oxidative-stress-and-antioxidants-in-atopic-dermatitis/50964/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Francisca Kartono, DO, FAAD, discuss the International Journal of Molecular Sciences article “The Role of Oxidative Stress and Antioxidants in the Course of Atopic Dermatitis.”Hypopigmentation in Atopic Dermatitis Patients with Skin of Color
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/program-name/57018/Cheri Frey, MD, describes how atopic dermatitis can present differently in skin of color.Addressing Unmet Needs in Rare Skin Diseases
https://practicaldermatology.com/videos/c-suite-chats/addressing-unmet-needs-in-rare-skin-diseases/67376/LEO Pharma VP of Rare Disease Lukasz Jarzyna discusses an industry shift toward the massive, untapped market of unmet needs in rare skin diseases such as generalized pustular psoriasis and the current awareness campaign around that particular condition.Zasocitinib Psoriasis Studies Continue to Show Promise
https://practicaldermatology.com/videos/skin-minute/zasocitinib-psoriasis-studies-continue-to-show-promise/67371/Linda Stein Gold, MD, explains the significance of new Phase 3 data on zasocitinib for psoriasis, demonstrating consistent, high rates of skin clearance across the body, including hard-to-treat and high-impact sites.Advancing the Science and Care of Pigmentary Disorders
https://practicaldermatology.com/topics/pigmentary-disorders/advancing-the-science-and-care-of-pigmentary-disorders/67251/These articles reflect the growing sophistication of our understanding of pathogenesis, advances in diagnostic and assessment tools, and the expanding therapeutic landscape that is reshaping patient care.Treating the Skin Barrier to Improve Eczema
https://practicaldermatology.com/videos/c-suite-chats/treating-the-skin-barrier-to-improve-eczema/67055/Ratan K. Chaudhuri, PhD, Founder and CEO of CuralysisMD Dermaceuticals, discusses the importance of addressing the skin barrier when treating atopic dermatitis.How to Get Young People to Wear Sunscreen
https://practicaldermatology.com/videos/skin-minute/how-to-get-young-people-to-wear-sunscreen/60875/SPOOGE Founder Whitney Hovenic, MD, discusses younger generations' insufficient utilization of sunscreen and the strategies her company has employed in an effort to avoid an increase in melanoma cases in the future.